JUBILANT PHARMOVA (India) Today

JUBLPHARMA -  India Stock  

INR 617.60  2.70  0.44%

JUBILANT PHARMOVA is trading at 617.60 as of the 26th of September 2021, a -0.44% down since the beginning of the trading day. The stock's open price was 620.3. JUBILANT PHARMOVA has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for JUBILANT PHARMOVA LTD are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of October 2019 and ending today, the 26th of September 2021. Click here to learn more.
 Market Performance
0 of 100
  Odds Of Distress
Less than 36
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

JUBILANT PHARMOVA Stock Profile

Jubilant Pharmova Limited operates as an integrated pharmaceutical company worldwide. The company was incorporated in 1978 and is based in Noida, India. JUBILANT PHARMOVA operates under Drug ManufacturersSpecialty Generic classification in India and is traded on National Stock Exchange of India. It employs 5800 people. more on JUBILANT PHARMOVA
JUBILANT PHARMOVA generates negative expected return over the last 90 days
About 58.0% of the company shares are held by company insiders
Legal NameJUBILANT PHARMOVA LTD
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of JUBILANT PHARMOVA's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
JUBILANT PHARMOVA LTD (JUBLPHARMA) is traded on National Stock Exchange of India in India and employs 5,800 people. The company currently falls under 'Mega-Cap' category with current market capitalization of 132.05 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate JUBILANT PHARMOVA's market, we take the total number of its shares issued and multiply it by JUBILANT PHARMOVA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. JUBILANT PHARMOVA LTD operates under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 159.28 M outstanding shares.
Check JUBILANT PHARMOVA Probability Of Bankruptcy
Ownership
JUBILANT PHARMOVA LTD secures a total of one hundred fifty-nine million two hundred eighty thousand outstanding shares. JUBILANT PHARMOVA shows noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how much assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check JUBILANT Ownership Details

JUBILANT Stock Price Odds Analysis

What are JUBILANT PHARMOVA's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of JUBILANT PHARMOVA jumping above the current price in 90 days from now is about 73.68%. The JUBILANT PHARMOVA LTD probability density function shows the probability of JUBILANT PHARMOVA stock to fall within a particular range of prices over 90 days. Assuming the 90 days trading horizon JUBILANT PHARMOVA LTD has a beta of -0.1801. This indicates as returns on benchmark increase, returns on holding JUBILANT PHARMOVA are expected to decrease at a much lower rate. During the bear market, however, JUBILANT PHARMOVA LTD is likely to outperform the market. Additionally, the company has an alpha of 0.336, implying that it can generate a 0.34 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 617.6HorizonTargetOdds Up 617.6 
26.24%90 days
 617.60 
73.68%
Based on a normal probability distribution, the odds of JUBILANT PHARMOVA to move above the current price in 90 days from now is about 73.68 (This JUBILANT PHARMOVA LTD probability density function shows the probability of JUBILANT Stock to fall within a particular range of prices over 90 days) .

JUBILANT PHARMOVA LTD Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. JUBILANT PHARMOVA market risk premium is the additional return an investor will receive from holding JUBILANT PHARMOVA long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in JUBILANT PHARMOVA. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although JUBILANT PHARMOVA's alpha and beta are two of the key measurements used to evaluate JUBILANT PHARMOVA's performance over the market, the standard measures of volatility play an important role as well.

JUBILANT Stock Against Markets

Picking the right benchmark for JUBILANT PHARMOVA stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in JUBILANT PHARMOVA stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for JUBILANT PHARMOVA is critical whether you are bullish or bearish towards JUBILANT PHARMOVA LTD at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in JUBILANT PHARMOVA without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module
Please see Risk vs Return Analysis. Note that the JUBILANT PHARMOVA LTD information on this page should be used as a complementary analysis to other JUBILANT PHARMOVA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Tools for JUBILANT Stock

When running JUBILANT PHARMOVA LTD price analysis, check to measure JUBILANT PHARMOVA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JUBILANT PHARMOVA is operating at the current time. Most of JUBILANT PHARMOVA's value examination focuses on studying past and present price action to predict the probability of JUBILANT PHARMOVA's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move JUBILANT PHARMOVA's price. Additionally, you may evaluate how the addition of JUBILANT PHARMOVA to your portfolios can decrease your overall portfolio volatility.
CEO Directory
Screen CEOs from public companies around the world
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go